208.12美元2.5(1.19%)
2026/01/19更新
績效 / 1月0.4%
3月4.52%
1年8.62%
晨星評等 淨值走勢
基金總覽
基金規模270.25百萬截至 2026-01-16
持股明細 / 風險評估
- 1.美國88.92%
- 2.歐洲不包含歐元區3.97%
- 3.英國2.33%
- 4.歐元區1.54%
- 1.Eli Lilly and Co9.82%
- 2.Boston Scientific Corp6.60%
- 3.AbbVie Inc5.11%
- 4.Cencora Inc4.71%
- 5.AstraZeneca PLC ADR4.29%
- 1.美國88.92%
- 2.歐洲不包含歐元區3.97%
- 3.英國2.33%
- 4.歐元區1.54%
- 1.Eli Lilly and Co9.82%
- 2.Boston Scientific Corp6.60%
- 3.AbbVie Inc5.11%
- 4.Cencora Inc4.71%
- 5.AstraZeneca PLC ADR4.29%